107 search results for: chronic inflammation

AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
Type 2 Inflammation
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
videoanimation

Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.

View more
<b>Chronic</b> Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
interactivity

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

View more
EAACI PAAM 2025 | How Type 2 <b>Inflammation</b> Shapes a Lifetime
Type 2 Inflammation
EAACI PAAM 2025 | How Type 2 Inflammation Shapes a Lifetime
expert video

Join ADVENT faculty members Len Bacharier, Antonella Cianferoni, and Andre Moreira for an educational symposium highlighting type 2 inflammation and its shared and distinct roles in multiple chronic pediatric diseases.

View more
What Drives <b>Chronic</b> Itch and the Itch-Scratch Cycle in Atopic Dermatitis?
Dermatology
What Drives Chronic Itch and the Itch-Scratch Cycle in Atopic Dermatitis?
videoanimation

Watch this short video to learn how type 2 inflammation, skin barrier dysfunction, and neurosensitization contribute to chronic itch and the itch-scratch cycle in atopic dermatitis

View more
Understanding IL-33: A Key Factor in COPD Pathogenesis
Pulmonology
Understanding IL-33: A Key Factor in COPD Pathogenesis
interactivity

Explore the role of interleukin (IL)-33 in chronic obstructive pulmonary disease (COPD) pathophysiology and its potential as a therapeutic target.

View more
Demystifying CPUO: Diagnosis and the Role of Type 2 <b>Inflammation</b>
Dermatology
Demystifying CPUO: Diagnosis and the Role of Type 2 Inflammation
expert video

Join Dr. Brian Kim in discussing the diagnosis of CPUO and the role of type 2 inflammation in disease pathophysiology.

View more
EoE: A <b>Chronic</b>, Progressive, Type 2 Inflammatory Disease Infographic
Gastroenterology
EoE: A Chronic, Progressive, Type 2 Inflammatory Disease Infographic
Infographic

Learn about key drivers of type 2 inflammation in EoE and how they mediate progressive esophageal remodeling and impact patient burden

View more
From Protective Type 2 Immunity to Aberrant Type 2 <b>Inflammation</b>
Type 2 Inflammation
From Protective Type 2 Immunity to Aberrant Type 2 Inflammation
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Oscar Palomares explains how type 2 immunity evolved to protect against parasites, venoms, and toxins, and how its dysregulation can result in aberrant type 2 inflammation underlying multiple chronic inflammatory diseases.

View more
Type 2 <b>Inflammation</b> Is a Driving Factor for Atopic Dermatitis and Related Comorbidities
Dermatology
Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities
expert video

Dr. Lawrence Eichenfield describes the pathophysiology of atopic dermatitis and how type 2 inflammation may sensitize patients to atopic comorbidities.

View more
Beyond the Visible: The Cumulative Burden of Prurigo Nodularis
Dermatology
Beyond the Visible: The Cumulative Burden of Prurigo Nodularis
expert video

Professor Matthias Augustin emphaizes that prurigo nodularis is a chronic systemic disease with a significant and multifaceted burden, encompassing both visible skin manifestations and hidden psychosocial and physical comorbidities.

View more
thumbnail
Congress
17
May
2026
Congress
ADVENT at ATS 2026

At ATS 2026, the Sanofi & Regeneron ADVENT Booth #1301 brings together interactive experiences and educational resources to explore Type 2 inflammation as a key feature underlying both asthma and COPD.​

Prurigo Nodularis: Type 2 <b>Inflammation</b> Links Neuronal Dysfunction and Fibrosis
Dermatology
Prurigo Nodularis: Type 2 Inflammation Links Neuronal Dysfunction and Fibrosis
interactivity

This infographic highlights how PN is driven by type 2 inflammation, linking immune dysregulation, fibroblast activation, and neuronal dysfunction to nodule formation. It also shows how cytokine-mediated changes in neuronal architecture increase excitability and chronic itch, where resulting lesions and scarring significantly impact patients’ psychological well-being.

View more